Literature DB >> 21871465

Modulation of fear/anxiety responses, but not food intake, following α-adrenoceptor agonist microinjections in the nucleus accumbens shell of free-feeding rats.

Larissa Kochenborger1, Débora Zanatta, Luigi Marins Berretta, Ana Paula Fraga Lopes, Bruna Luiza Wunderlich, Ana Cláudia Januário, José Marino Neto, Mariana Graciela Terenzi, Marta Aparecida Paschoalini, Moacir Serralvo Faria.   

Abstract

This study investigated the effect of α-adrenoceptor agonists microinjected into the shell region of the accumbens nucleus (AcbSh) on feeding and anxiety-related behaviors in free-feeding rats. Male Wistar rats with a chronically implanted cannula into the AcbSh were unilaterally microinjected with either clonidine (CLON, α(2)-adrenoceptor agonist) or phenylephrine (PHEN, α(1)-adrenoceptor agonist) at the doses of 6 and 20 nmol and submitted to the elevated plus-maze (EPM), a pre-clinical test of anxiety. Immediately after the EPM test, the animals underwent food intake evaluation for 30 min. The data showed that rats microinjected with CLON (20 nmol/0.2 μl) into the AcbSh exhibited increased %Open arm time, which is compatible with an anxiolytic-like effect. The CLON-induced anxiolysis was corroborated by increased head-dipping and decreased stretched-attend posture, two ethologically derived behaviors which are fear/anxiety-motivated. The animal's locomotor activity was not changed by 20 nmol CLON microinjection into the AcbSh. However, neither dose of PHEN microinjected into the AcbSh was able to alter either the spatial-temporal or ethological variables representative of fear/anxiety and locomotion. Food intake was not altered by any dose of CLON and PHEN microinjected into the AcbSh, but the 20 nmol CLON microinjection induced increased motor activity in the feeding test. The data suggests that noradrenergic projections to the AcbSh may underlie fear/anxiety modulation through α(2)-adrenoceptor in the AcbSh, while feeding behavior was unaffected by noradrenergic modulation in the AcbSh of free-feeding rats. This article is part of a Special Issue entitled 'Anxiety and Depression'.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21871465     DOI: 10.1016/j.neuropharm.2011.08.019

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  5 in total

1.  microRNA-15b contributes to depression-like behavior in mice by affecting synaptic protein levels and function in the nucleus accumbens.

Authors:  Li Guo; Zhaoming Zhu; Guangyan Wang; Shan Cui; Meng Shen; Zhenhua Song; Jin-Hui Wang
Journal:  J Biol Chem       Date:  2020-03-24       Impact factor: 5.157

2.  Lateral hypothalamus-projecting noradrenergic locus coeruleus pathway modulates binge-like ethanol drinking in male and female TH-ires-cre mice.

Authors:  Nathan W Burnham; Corryn N Chaimowitz; Cortland C Vis; Ana Paula Segantine Dornellas; Montserrat Navarro; Todd E Thiele
Journal:  Neuropharmacology       Date:  2021-07-08       Impact factor: 5.273

3.  Gut Dysbiosis and Neurobehavioral Alterations in Rats Exposed to Silver Nanoparticles.

Authors:  Angela B Javurek; Dhananjay Suresh; William G Spollen; Marcia L Hart; Sarah A Hansen; Mark R Ellersieck; Nathan J Bivens; Scott A Givan; Anandhi Upendran; Raghuraman Kannan; Cheryl S Rosenfeld
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

4.  Beneficial Effects of Highly Palatable Food on the Behavioral and Neural Adversities induced by Early Life Stress Experience in Female Rats.

Authors:  Jin Young Kim; Jong-Ho Lee; Doyun Kim; Soung-Min Kim; JaeHyung Koo; Jeong Won Jahng
Journal:  Int J Biol Sci       Date:  2015-08-01       Impact factor: 6.580

5.  Noradrenaline-induced release of newly-synthesized accumbal dopamine: differential role of alpha- and beta-adrenoceptors.

Authors:  Francisca Meyer; Judith Latour; Alexander R Cools; Michel M M Verheij
Journal:  Front Cell Neurosci       Date:  2014-08-21       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.